{"id":"NCT00746096","sponsor":"Nobelpharma","briefTitle":"Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea","officialTitle":"Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2008-09-03","resultsPosted":"2014-06-13","lastUpdate":"2025-03-06"},"enrollment":115,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Dysmenorrhea"],"interventions":[{"type":"DRUG","name":"IKH-01","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"IKH-01","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.","primaryOutcome":{"measure":"Patient Response to Treatment for Primary Dysmenorrhea, as Evaluated by Difference of Total Dysmenorrhea Score (Baseline/Pretreatment-End of Treatment)","timeFrame":"16weeks","effectByArm":[{"arm":"IKH-01","deltaMin":3.8,"sd":0.94},{"arm":"Placebo","deltaMin":3.6,"sd":0.71}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21420678"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":["Metrorrhagia","Nasopharyngitis","Oligomenorrhoea","Nausea","Headache"]}}